Galectin Therapeutics Inc (GALT)
3.34
-0.03
(-0.89%)
USD |
NASDAQ |
May 03, 16:00
3.36
+0.02
(+0.60%)
After-Hours: 20:00
Galectin Therapeutics Market Cap: 206.76M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 206.76M |
| May 02, 2024 | 208.62M |
| May 01, 2024 | 216.66M |
| April 30, 2024 | 217.28M |
| April 29, 2024 | 222.85M |
| April 26, 2024 | 213.57M |
| April 25, 2024 | 216.66M |
| April 24, 2024 | 203.66M |
| April 23, 2024 | 209.23M |
| April 22, 2024 | 189.43M |
| April 19, 2024 | 208.62M |
| April 18, 2024 | 209.23M |
| April 17, 2024 | 209.23M |
| April 16, 2024 | 210.47M |
| April 15, 2024 | 242.04M |
| April 12, 2024 | 245.76M |
| April 11, 2024 | 260.00M |
| April 10, 2024 | 236.47M |
| April 09, 2024 | 243.90M |
| April 08, 2024 | 231.52M |
| April 05, 2024 | 230.90M |
| April 04, 2024 | 185.71M |
| April 03, 2024 | 176.43M |
| April 02, 2024 | 155.38M |
| April 01, 2024 | 151.04M |
| Date | Value |
|---|---|
| March 28, 2024 | 147.95M |
| March 27, 2024 | 149.19M |
| March 26, 2024 | 146.71M |
| March 25, 2024 | 144.24M |
| March 22, 2024 | 151.04M |
| March 21, 2024 | 151.04M |
| March 20, 2024 | 136.19M |
| March 19, 2024 | 130.00M |
| March 18, 2024 | 132.47M |
| March 15, 2024 | 127.52M |
| March 14, 2024 | 122.57M |
| March 13, 2024 | 122.57M |
| March 12, 2024 | 121.95M |
| March 11, 2024 | 124.43M |
| March 08, 2024 | 126.28M |
| March 07, 2024 | 129.38M |
| March 06, 2024 | 128.76M |
| March 05, 2024 | 127.52M |
| March 04, 2024 | 123.19M |
| March 01, 2024 | 119.47M |
| February 29, 2024 | 121.02M |
| February 28, 2024 | 116.90M |
| February 27, 2024 | 115.05M |
| February 26, 2024 | 116.28M |
| February 23, 2024 | 116.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
61.21M
Minimum
Dec 28 2022
291.65M
Maximum
Apr 28 2021
142.08M
Average
129.56M
Median
Dec 28 2020
Market Cap Benchmarks
| Madrigal Pharmaceuticals Inc | 4.573B |
| Viking Therapeutics Inc | 8.487B |
| 89bio Inc | 877.97M |
| Terns Pharmaceuticals Inc | 351.71M |
| Enanta Pharmaceuticals Inc | 320.94M |
Market Cap Related Metrics
| Price | 3.34 |
| Earnings Yield | -22.16% |